港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

528.144

+15.3713.00%

漲家數：26

跌家數：5

平家數：2

市盈率：- -

高：540.538

開：513.718

低：513.718

收：512.773

成交量：1.10億

成交額：40.00億

市值：3,382.37億

流通市值：3,004.76億

資料載入中...

總覽新聞資訊

A股收評：創業板指跌超3%，醫藥、算力硬件股齊挫，貴金屬逆勢走強！

恒瑞醫藥半年報解讀：高投入難換高增長昔日「醫藥一哥」增收難增利

A股收評：創業板指跌3.21%，超3900股下跌，醫藥、算力硬件板塊集體回調

大行評級丨野村：中生製藥上半年業績強勁，目標價升至8.67港元

啓明醫療－Ｂ(02500)股價下跌5.882%，現價港幣$0.96

阿斯达克财经

中金：維持歸創通橋(02190.HK)跑贏行業評級目標價32港元

瀋陽：違規售賣獸用管制藥，2家門店被立案調查

和鉑醫藥-B(02142.HK)被納入恒生綜合指數成份股

沛嘉醫療2026年中期業績：集團首次實現税前盈利，TAVR植入量按年增長36.5%

龍航資產蔡英明：堅守價值成長看好AI和創新藥兩大方向

东方财富网

《業績》永泰生物(06978.HK)中期虧損收窄至6,987萬人民幣

阿斯达克财经

《業績》沛嘉醫療(09996.HK)中期虧損收窄至759萬人民幣

阿斯达克财经

敦煌醫藥文化跨界出圈　「滋補」絲路康養遊

中国新闻网

《盈警》億騰嘉和(06998.HK)預告半年轉虧最少6,000萬人民幣

阿斯达克财经

從預防到治療，mRNA疫苗創造歷史！醫藥圈炸鍋，一文讀懂產業鏈機會

《盈警》歌禮制藥(01672.HK)預告中期虧損擴至3.2億人民幣

阿斯达克财经

歸創通橋(02190)8月21日斥資約7.22萬港元回購3500股

《業績》東曜藥業(01875.HK)中期虧損5,852萬人民幣盈轉虧

阿斯达克财经

麗珠醫藥(01513.HK)近1.1億人民幣增持新北江製藥至90.64%

阿斯达克财经

方正策略：美債利率施壓、科技股敍事生變弱美元下資源與醫藥板塊獲機構青睞

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/BK1574/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":528.14417,"timestamp":1787724981885,"preClose":512.7729,"halted":0,"volume":110408522,"delay":0,"changeRate":0.029977,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":15.371277,"latestTime":"08-26 14:16:22","open":513.7177,"high":540.53845,"low":513.7177,"amount":3999797983,"amplitude":0.052305,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787731800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787707800000,1787716800000],[1787720400000,1787731200000]],"pbRate":3.84011,"peRate":154.066227,"turnoverRate":0.004008,"increases":26,"decrements":5,"flats":2,"marketCap":338237243728,"floatMarketCap":300476140912},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":540.53845,"amplitude":0.052305,"preClose":512.7729,"low":513.7177,"pbRate":"3.84011","latestPrice":528.14417,"volume":110408522,"delay":0,"open":513.7177,"prevYearClose":556.26263,"prevWeekClose":506.075,"prevMonthClose":473.313,"prevQuarterClose":453.519,"fiveDayClose":492.831,"twentyDayClose":481.996,"sixtyDayClose":519.865,"secType":"PLATE","market":"HK","turnoverRate":0.004008,"peRate":154.066227,"marketCap":338237243728,"floatMarketCap":300476140912,"timestamp":1787724981885,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":26,"down":5,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661229354","title":"A股收評：創業板指跌超3%，醫藥、算力硬件股齊挫，貴金屬逆勢走強！","url":"https://stock-news.laohu8.com/highlight/detail?id=2661229354","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661229354?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 15:36","pubTimestamp":1787556987,"startTime":"0","endTime":"0","summary":"全市场超3900只个股下跌","market":"fut","thumbnail":"https://img7.gelonghui.com/column/2/101.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/101.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6255104","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1147","399006","83130","399001","LU1993786604.SGD","82846","000001","83188","BK0278","DBP","LU0880133367.SGD","LU1781817850.SGD","LU0501845795.SGD","02827","07234","BK0028","LU0072913022.USD","IE00B0JY6N72.USD","BK1161","09939","BK0012","LU1580142542.USD","BK0183","YSAG","BK0187","LU1226287529.USD","LU0067412154.USD","03188","03147","07233","159982","LU1655091616.SGD","BK1515","BK0188","399300","BK1574","03130","LU1807302812.USD","02846","BK0201","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661293262","title":"恒瑞醫藥半年報解讀：高投入難換高增長   昔日「醫藥一哥」增收難增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2661293262","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661293262?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 15:17","pubTimestamp":1787555820,"startTime":"0","endTime":"0","summary":"2026年8月，恒瑞医药正式对外披露半年报，这份被市场寄予厚望的中期成绩单，未能延续行业对“创新药龙头复苏高增长”的预期。上半年总营收154.56亿元，同比2025年同期157.61亿元下滑1.9%，出现阶段性半年度营收负增长。证监会黑龙江监管局处罚文书显示，恒瑞医药前董事长周云曙在职期间，利用行业合作内幕信息交易司太立股票，违法获利45万元，监管部门2025年9月作出处罚，没收全部违法所得并处50万元罚款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-08-24/doc-inipkzxr0043463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1580142542.USD","LU2097828474.EUR","LU0405327494.USD","LU1997245177.USD","LU2097828631.EUR","BK0188","LU1781817850.SGD","BK1574","LU1820825898.SGD","LU1969619763.USD","LU1064131003.USD","LU2543165471.USD","BK1161","LU0405327148.USD","600276","LU1655091616.SGD","LU0359202008.SGD","LU2097828805.USD","LU2580892862.HKD","BK0028","LU1146622755.USD","LU2148510915.USD","LU2488822045.USD","LU1064130708.USD","BK0196","BK0060","LU2097828714.EUR","BK0239","BK1515","159938","BK1191","LU1023057109.AUD","LU2097828557.USD","BK0012","LU2580892789.USD","BK0183","01276","LU1328615791.USD","LU1997244956.HKD","LU1997245094.SGD","LU0359201612.USD","LU0359201885.HKD","LU2495084118.USD","LU1255011170.USD","LU2328871848.SGD","09939","LU2289578879.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661226352","title":"A股收評：創業板指跌3.21%，超3900股下跌，醫藥、算力硬件板塊集體回調","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226352","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661226352?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 15:05","pubTimestamp":1787555154,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["07233","07234","BK1147","BK1574","399001","03130","83188","399006","159938","159982","BK1515","83130","03147","82846","BK1161","02846","399300","02827","03188","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661259462","title":"大行評級丨野村：中生製藥上半年業績強勁，目標價升至8.67港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661259462","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661259462?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 14:36","pubTimestamp":1787553401,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1574","01477","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661246247","title":"啓明醫療－Ｂ(02500)股價下跌5.882%，現價港幣$0.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2661246247","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661246247?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 11:00","pubTimestamp":1787540400,"startTime":"0","endTime":"0","summary":"[下跌股]启明医疗－Ｂ(02500) 股价在上午11:00比前收市价下跌5.882%，现股价为港币$0.96。至目前为止，今日最高价为$1.02，而最低价为$0.96。总成交量为1.15万股，总成交金额为港币$1.164万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2608243785/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2608243785/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","02500","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661444302","title":"中金：維持歸創通橋(02190.HK)跑贏行業評級 目標價32港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661444302","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661444302?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 09:20","pubTimestamp":1787534404,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02190","BK1574","BK1583","BK1100","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661241201","title":"瀋陽：違規售賣獸用管制藥，2家門店被立案調查","url":"https://stock-news.laohu8.com/highlight/detail?id=2661241201","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661241201?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 08:40","pubTimestamp":1787532000,"startTime":"0","endTime":"0","summary":"格隆汇8月24日｜8月24日，沈阳于洪区农业农村局发布情况通报：8月23日，媒体报道沈阳市张士物流园兽药门店违规售卖兽用管制药品问题，于洪区农业农村局高度重视，联合区公安分局迅速开展现场核查处置。现已对涉事两家门店涉案药品和经营台账当场封存，并依法立案调查，对违法经营行为，坚决查处绝不姑息。下一步，我区将全面开展兽用管制药品专项排查整治，压实监管责任，规范行业经营秩序，自觉接受社会监督。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-08-24/doc-inipkmaa6278126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661124140","title":"和鉑醫藥-B(02142.HK)被納入恒生綜合指數成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661124140","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661124140?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 08:37","pubTimestamp":1787531852,"startTime":"0","endTime":"0","summary":"格隆汇8月24日丨和铂医药-B(02142.HK)发布公告，公司已获恒生指数有限公司选定并将被纳入恒生综合指数成份股，自2026年9月7日起生效。被纳入恒生综合指数成份股后，公司股份预计将符合沪港通及深港通交易的纳入标准。\r\n\r\n　　董事会认为，被纳入恒生综合指数成份股反映了资本市场对公司业务表现及价值的高度认可，其将有助于扩大公司的股东基础并增加股份交易的流动性，从而持续提高公司于资本市场的投资价值及声誉。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260824/32344164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["HSCI","BK1574","BK1583","BK1161","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661924198","title":"沛嘉醫療2026年中期業績：集團首次實現税前盈利，TAVR植入量按年增長36.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661924198","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661924198?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 08:00","pubTimestamp":1787529600,"startTime":"0","endTime":"0","summary":"与此同时，集团经营活动产生的现金净额达到人民币4,941万元，同比增长1,394.5%。2026年上半年，集团实现毛利人民币2.90亿元，同比增长17.1%，整体毛利率为68.3%，较去年同期70.1%下降1.8个百分点。2026年上半年，经导管瓣膜治疗业务分部亏损同比大幅收窄87.2%至人民币972万元；神经介入业务分部利润则同比增长79.0%至人民币7,320万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5031829_ZH31829_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5031829_ZH31829_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1574","09996","BK1583","BK4202","AS","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661005249","title":"龍航資產蔡英明：堅守價值成長 看好AI和創新藥兩大方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2661005249","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661005249?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 01:45","pubTimestamp":1787507154,"startTime":"0","endTime":"0","summary":"经历多轮行情，龙航资产董事长兼投资总监蔡英明逐步打磨出一套价值成长投资体系。他坚持立足基本面研究，赚企业成长的钱，在波动市场中寻找高确定性投资机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/11846,202608243850440080.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/11846,202608243850440080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["06978","AGIX","CHAT","VTHR","BK1574","IBBQ","ARTY","LNGR","AIPO","BK1161","159992","MEDX","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661824366","title":"《業績》永泰生物(06978.HK)中期虧損收窄至6,987萬人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2661824366","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661824366?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 22:06","pubTimestamp":1787493960,"startTime":"0","endTime":"0","summary":"永泰生物－Ｂ(06978.HK) 公布6月止六个月中期业绩，其他收入录得1,260万人民币(下同)，按年下降3.4%。亏损由上年同期1.29亿元，收窄至6,987万元，每股亏损11分。不派息。(d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2026/03/20末期业绩无派息2025/09/19特别业绩供股: 5股供1股@港元 2.50002025/08/20中期业绩无派息2025/03/31末期业绩无派息AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210812112201207_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210812112201207_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540128/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540128/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["UCmain","BK1161","BK1574","MCNHmain","CNHmain","06978","MUCmain","CYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661243801","title":"《業績》沛嘉醫療(09996.HK)中期虧損收窄至759萬人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2661243801","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661243801?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 21:08","pubTimestamp":1787490480,"startTime":"0","endTime":"0","summary":"沛嘉医疗－Ｂ(09996.HK) 公布6月止六个月中期业绩，收入4.25亿人民币(下同)，按年增加20.1%。亏损由上年同期6,988万元，收窄至759万元，每股亏损1分。不派息。(d)(港股报价延迟最少十五分钟。沽空资料截至 2026-08-21 16:25。)过往派息公布日期派息事项派息内容2026/03/25末期业绩无派息2025/08/22中期业绩无派息2025/03/26末期业绩无派息2024/08/23中期业绩无派息AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200911173949451_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200911173949451_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540119/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540119/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["MUCmain","159891","CYB","CNHmain","BK1574","BK1100","09996","BK1583","MCNHmain","UCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661243883","title":"敦煌醫藥文化跨界出圈　「滋補」絲路康養遊","url":"https://stock-news.laohu8.com/highlight/detail?id=2661243883","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661243883?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 20:48","pubTimestamp":1787489280,"startTime":"0","endTime":"0","summary":"今年暑期，敦煌壁画里的“艾灸图”，敦煌经卷里的“验方集”，敦煌文献里的“神仙粥”等丰富多彩的敦煌医药文化“走出”洞窟和典籍，化作针灸推拿、艾灸刮痧、三伏贴等游人可感可知的诊疗服务，在市井烟火中火爆出圈，持续“滋补”丝路康养游。据官方统计，在敦煌藏经洞中，共保存医方类文献残卷34个。图为8月12日在敦煌市中医医院“敦煌医学展馆”里呈现的敦煌医学著作。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-08-23/doc-inipiiqs3472147.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-23/doc-inipiiqs3472147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1515","159938","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661438802","title":"《盈警》億騰嘉和(06998.HK)預告半年轉虧最少6,000萬人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2661438802","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661438802?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 20:47","pubTimestamp":1787489220,"startTime":"0","endTime":"0","summary":"亿腾嘉和(06998.HK) 发盈警，预计6月止六个月亏损介乎6,000万至7,000万人民币，相较上年同期利润1.15亿人民币，盈转亏主要由于市场对集中采购的提前反应对集团销售造成不利影响，以及研发开支增加。期间收入介乎8.5亿至9亿人民币，上年同期为11.36亿人民币。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-08-21 16:25。)过往派息公布日期派息事项派息内容2026/03/27末期业绩无派息2025/08/29中期业绩无派息2025/03/30末期业绩无派息2024/08/28中期业绩无派息AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141800042_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141800042_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540114/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540114/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["MUCmain","UCmain","CYB","CNHmain","MCNHmain","06998","BK1583","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661484362","title":"從預防到治療，mRNA疫苗創造歷史！醫藥圈炸鍋，一文讀懂產業鏈機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2661484362","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661484362?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 19:15","pubTimestamp":1787483700,"startTime":"0","endTime":"0","summary":"不同于预防性mRNA疫苗用于健康人群，mRNA-4157/V940是一款肿瘤治疗性mRNA疫苗，用于黑色素瘤癌症患者术后辅助治疗，防止癌症复发。mRNA-4157/V940是人类历史上首个在三期临床证明有效的个性化mRNA癌症疗法。疫苗行业的天花板一下子从百亿级的传染病预防市场，跃升到了千亿级的肿瘤治疗市场。诚通证券指出，治疗性mRNA肿瘤疫苗III期临床成功打开癌症治疗创新药和创新疗法新的空间，mRNA产业链和创新药产业链有望持续受益，看好mRNA产业链、PD-1联合治疗、创新药板块。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-23/doc-inipichq2436852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MRNX","159938","BK1515","09939","BK1574","BK1161","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661024898","title":"《盈警》歌禮制藥(01672.HK)預告中期虧損擴至3.2億人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2661024898","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661024898?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 18:34","pubTimestamp":1787481240,"startTime":"0","endTime":"0","summary":"歌礼制药－Ｂ(01672.HK) 发盈警，预计6月止六个月亏损约3.2亿人民币，相较上年同期录得8,800万人民币，增幅263.5%。亏损增加主要是由于研发开支大幅增加132.7%至3.42亿人民币。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-08-21 16:25。)过往派息公布日期派息事项派息内容2026/03/31末期业绩无派息2025/08/15中期业绩无派息2025/03/26末期业绩无派息2024/08/30中期业绩无派息AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200428144141002_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200428144141002_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540067/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540067/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["CNHmain","BK1515","BK1574","CYB","01672","BK1161","BK1191","UCmain","01477","MUCmain","MCNHmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661691248","title":"歸創通橋(02190)8月21日斥資約7.22萬港元回購3500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661691248","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661691248?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 18:31","pubTimestamp":1787481064,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2026年8月21日该公司斥资约7.22万港元回购3500股，回购价格为每股20.6至20.62港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483885.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1574","BK1587","02190","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661124861","title":"《業績》東曜藥業(01875.HK)中期虧損5,852萬人民幣  盈轉虧","url":"https://stock-news.laohu8.com/highlight/detail?id=2661124861","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661124861?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 18:24","pubTimestamp":1787480640,"startTime":"0","endTime":"0","summary":"东曜药业－Ｂ(01875.HK) 公布6月止六个月中期业绩，收益2.46亿人民币(下同)，按年下降49.7%。录得亏损5,852万元，相较上年同期纯利406万元，盈转亏；每股亏损8分。不派息。(d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2026/03/18末期业绩无派息2025/11/11第三季业绩无派息2025/08/12中期业绩无派息2025/05/12第一季业绩无派息AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220720120329316_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220720120329316_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540060/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540060/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["CNHmain","BK1574","CYB","01875","MCNHmain","UCmain","BK1161","MUCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661341248","title":"麗珠醫藥(01513.HK)近1.1億人民幣增持新北江製藥至90.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661341248","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661341248?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 18:03","pubTimestamp":1787479380,"startTime":"0","endTime":"0","summary":"丽珠医药(01513.HK) 公布关连交易，向中汇源收购新北江制药3.5%股权，现金代价1.07亿人民币。完成后，公司于新北江制药持股将由87.14%增至90.64%，后者主要从事原料药和中间体的生产。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-08-21 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240410110807807_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240410110807807_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540035/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540035/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["UCmain","BK1191","CYB","01513","CNHmain","01477","MUCmain","BK1574","MCNHmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661141210","title":"方正策略：美債利率施壓、科技股敍事生變 弱美元下資源與醫藥板塊獲機構青睞","url":"https://stock-news.laohu8.com/highlight/detail?id=2661141210","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661141210?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 16:21","pubTimestamp":1787473314,"startTime":"0","endTime":"0","summary":"美债利率上行、海外科技叙事松动及国内经济数据偏弱压制风险偏好，资金向资源、银行等方向切换。展望后市，短期风险已有所释放，但外部利率及国内旺季成色仍待观察，配置上可逢低关注科技细分、弱美元受益资产及医药核心龙头。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07261","UDN","BK1147","XLK","BK1574","07522","09086","03455","07266","VGT","BK4588","UUP","09939","BK1161","DBND","03086","09834","03034","159938","07568","BK1515","BK4585","TTTN","02834"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":5,"totalSize":381,"code":"91000000","status":"200"}]}}